Market Exclusive

Abbott Laboratories (NYSE:ABT) reported earnings of $0.62 per share beating Walls Streets expectations.

Abbott Laboratories (NYSE:ABT) reported Q2 2017 earnings this Morning, coming in at $0.62 per share, beating Wall Street’s estimates of $0.60 per Share. Revenue for the quarter came in at $6.64 billion beating analyst estimates of $6.63 billion

Analyst Coverage For Abbott Laboratories (NYSE:ABT)
These are 3 Hold Ratings, 11 Buy Ratings .
The current consensus rating for Abbott Laboratories (NYSE:ABT) is Buy (Score: 2.79) with a consensus target price of $51.85 , a potential (4.89% upside)Recent Insider Trading for Abbott Laboratories (NYSE:ABT)

Dividend History for Abbott Laboratories (NYSE:ABT)

Recent Trading for Abbott Laboratories (NYSE:ABT) Shares of Abbott Laboratories closed the previous trading session at 50.27 up +0.84 1.70% with 6,484,975 shares trading hands.

Exit mobile version